Expertise in
5
conditions

Alison J. Birtle

Preston, ENG, GB 
Expertise in
5
conditions
Preston, ENG, GB 

Overview

Alison Birtle practices practicing medicine in Preston, United Kingdom.

Ms. Birtle is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Bladder Cancer, Urothelial Cancer, Orchiectomy, and Nephrectomy.

She is actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Preston, ENG, United Kingdom
Other Locations
Manchester, ENG, United Kingdom
Lancaster, ENG, United Kingdom
Lancashire, United Kingdom
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2020
Intervention Type: Radiation
Study Phase: Phase 2
A Randomized Phase II Trial of Carboplatin and Gemcitabine +/- Vandetanib in First Line Treatment of Advanced Urothelial Cell Cancer in Patients Who Are Not Suitable to Receive Cisplatin
A Randomized Phase II Trial of Carboplatin and Gemcitabine +/- Vandetanib in First Line Treatment of Advanced Urothelial Cell Cancer in Patients Who Are Not Suitable to Receive Cisplatin
Enrollment Status: Completed
Publish Date: May 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

125 Total Publications

Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.
Journal: European urology oncology
Published: April 21, 2026

Frequently Asked Questions about Alison J. Birtle

Is Alison J. Birtle a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alison J. Birtle is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alison J. Birtle participate in research or clinical trials?

Yes. Alison J. Birtle has published 125 articles and abstracts on conditions like Prostate Cancer. You can view a list of Alison J. Birtle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Birtle's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile